InVision Medical Technology Corporation @InVision_AI

AI Echocardiography Interpretation and Diagnosis. Backed by @YCombinator . Joined March 2023

Tweets

25
Followers

321
Following

0
Likes

36

David Ouyang, MD @David_Ouyang

2 months ago

We are excited to announce that both EchoPrime @milos_ai and EchoNet-Measurements @Yuki_Sahashi will be presented at the @ASE360 Scientific Sessions Late Breaking Science session! See you in September at #ASE2025 in Nashville!

3 6 27 4K 3

InVision Medical Technology Corporation @InVision_AI

3 months ago

InVision Precision Cardiac Amyloid receives FDA clearance. Previously receiving Breakthrough Designation, InVision PCA is an AI-#echofirst algorithm for the detection of AL and ATTR Cardiac Amyloidosis invisionmedtech.com/news/fda-clear…

0 4 12 4K 2

David Ouyang, MD @David_Ouyang

11 months ago

1/n We are excited to announce EchoPrime – the first echocardiography AI model capable of evaluating a full transthoracic echocardiogram study, identify the most relevant videos, and produce a comprehensive interpretation! Great work lead by @milos_ai, EchoPrime is the largest…

26 157 455 112K 172

Download Video

InVision Medical Technology Corporation @InVision_AI

a year ago

Congratulations to the HELIOS-B investigators! Early recognition of TTR amyloidosis leads to the most effective treatment of this deadly disease. Initiation of therapy at earlier stages lead to an even more dramatic impact on survival and decrease in cardiovascular events!

Ronald Witteles @Ron_Witteles

a year ago

1 0 9 3K 0

Download Image

0 1 3 1K 0

InVision Medical Technology Corporation @InVision_AI

a year ago

We are excited to announce a new CPT code for AI-enhanced echo for detection of Cardiac Amyloidosis! Yesterday, the AMA has issued new CPT code 0932T, a new Cat 3 CPT code to track InVision Precision Cardiac Amyloid usage starting 1/1/2025. invisionmedtech.com/news/cardiac-a…

0 2 10 3K 3

InVision Medical Technology Corporation @InVision_AI

a year ago

Thanks for highlighting our FDA clearance! We are excited to be the only echo AI tested in prospective RCT!

Cardiac Wire @Cardiac_Wire

a year ago

Thanks for highlighting our FDA clearance! We are excited to be the only echo AI tested in prospective RCT!

0 1 4 1K 3

0 0 3 888 0

InVision Medical Technology Corporation @InVision_AI

a year ago

We are proud to announce the FDA 510k clearance of Precision LVEF - the only AI-LVEF algorithm proven to provide time savings and improve clinician accuracy in blinded randomized clinical trial! invisionmedtech.com/news/invision-…

0 3 8 3K 1

InVision Medical Technology Corporation @InVision_AI

2 years ago

@InVision_AI is excited to participate in the @US_FDA's Total Product Life Cycle Advisory Program. We are excited to work with CRDH and OHT2 to evaluate InVision Cardiac Amyloidosis Screening. Our goal is to develop high-quality, safe, effective SaMD medical devices.

0 1 4 1K 0

David Ouyang, MD @David_Ouyang

2 years ago

We are thrilled to be funded by the @MooreFound and @KPDOR's AIM-HI initiative to study the deployment of AI to screen for cardiac amyloidosis working with an excellent team of physician scientists across four diverse sites. @Paul_P_Cheng @tygluckman @FarazAhmadMD @SmidtHeart…

6 9 76 9K 4

Download Image

InVision Medical Technology Corporation @InVision_AI

2 years ago

We are excited to announce InVision has secured FDA breakthrough device designation for #ai enabled #amyloidosis detection. The AI algorithm integrates information from multiple #echofirst views and is the only peer reviewed algorithm of its kind. invisionmedtech.com/post/fda-break…

0 3 25 13K 1

InVision Medical Technology Corporation @InVision_AI

2 years ago

We are excited to partner with @AlexionPharma to improve diagnosis of rare diseases, such as cardiac amyloidosis. Artificial intelligence can both improve speed and precision of diagnosis. invisionmedtech.com/post/invision-… @AlexionPharmaUS @AstraZeneca @Amyloidosis_ARC